948571-54-8

Basic information

• Product Name: tert-butyl [4-(benzyloxy)-2-methoxyphenyl]acetate
• Synonyms: tert-butyl [4-(benzyloxy)-2-methoxyphenyl]acetate
• CAS NO: 948571-54-8
• Molecular Weight: 328.408
• Mol File: 948571-54-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-butyl [4-(benzyloxy)-2-methoxyphenyl]acetate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl [4-(benzyloxy)-2-methoxyphenyl]acetate(948571-54-8)
• EPA Substance Registry System: tert-butyl [4-(benzyloxy)-2-methoxyphenyl]acetate(948571-54-8)

Safety Data

• Hazardous Substances Data: 948571-54-8(Hazardous Substances Data)

Upstream product

• 863310-59-2 [4-(benzyloxy)-2-methoxyphenyl]acetic acid 
• 36805-97-7 N,N-dimethylformamide di-tert-butyl acetal 
• 100-39-0 benzyl bromide 
• 18278-34-7 4-hydroxy-2-methoxybenzaldehyde 
• 58026-14-5 4-(benzyloxy)-2-methoxybenzaldehyde 
• 883985-70-4 2-(4-benzyloxy-2-methoxyphenyl)acetonitrile 
• 171768-67-5 4-benzyloxy-1-bromo-2-methoxybenzene 
• 321745-86-2 2-tert-butoxy-2-oxoethylzinc chloride 

Downstream Products

• 948573-82-8 tert-butyl 2-(4-benzyloxy-2-methoxyphenyl)propionate 
• 863310-59-2 [4-(benzyloxy)-2-methoxyphenyl]acetic acid 
• 1437778-86-3 1-(azetidin-1-yl)-2-[4-(benzyloxy)-2-methoxyphenyl]ethanone 
• 1437778-87-4 1-(azetidin-1-yl)-2-(4-hydroxy-2-methoxyphenyl)ethanone 
• 1437776-48-1 1-(azetidin-1-yl)-2-[4-(2-{(1S,2R)-2-[1-(5-chloropyrimidin-2-yl)piperidin-4-yl]cyclopropyl}ethoxy)-2-methoxyphenyl]ethanone 
• 952059-58-4 tert-butyl 2-[2-methoxy-4-(1,7-naphthyridin-4-yloxy)phenyl]acetate 
• 952059-80-2 2-[2-methoxy-4-(6-methoxy-1,5-naphthyridin-4-yloxy)phenyl]acetic acid 
• 952059-81-3 tert-butyl 2-[2-methoxy-4-(6-methoxy-1,5-naphthyridin-4-yloxy)phenyl]acetate 
• 952059-55-1 2-[2-methoxy-4-(1,7-naphthyridin-4-yloxy)phenyl]acetic acid 

Relevant articles and documents

SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS

Substituted cyclopropyl compounds of the formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR-119. Pharmaceutical compositions and methods of treatment are also included

NAPHTHYRIDINE DERIVATIVES AS ANTI-CANCER AGENTS

The invention concerns naphthyridine derivatives of Formula (I): or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, G1, G2, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders or disease states associated with angiogenesis and/or vascular permeability.